Emergent BioSolutions Inc (EBS)
8.30
+0.15
(+1.84%)
USD |
NYSE |
Dec 24, 16:00
Emergent BioSolutions Free Cash Flow: 138.10M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 6.486B |
| Tonix Pharmaceuticals Holding Corp | -69.19M |
| Chimerix Inc | -70.42M |
| Geron Corp | -216.50M |
| MAIA Biotechnology Inc | -15.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 153.70M |
| Cash from Investing (Quarterly) | 112.00M |
| Cash from Financing (Quarterly) | -180.30M |
| Free Cash Flow Per Share (Quarterly) | 2.660 |
| Free Cash Flow to Equity (Quarterly) | 347.50M |
| Free Cash Flow to Firm (Quarterly) | 154.59M |
| Free Cash Flow Yield | 31.32% |